2025-10-01 - Analysis Report
Okay, here's an analysis of First Solar Inc. (FSLR) based on the provided data, formatted for readability and including key takeaways:

## FSLR Stock Analysis (First Solar Inc.)

**First Solar Inc. is a leading provider of comprehensive photovoltaic (PV) solar energy solutions.**

### 1. Performance vs. S&P 500 (VOO)

*   **FSLR Cumulative Return:** 59.49%
*   **VOO Cumulative Return:** 97.56%
*   **Absolute Divergence:** -55.3% (FSLR underperformed VOO)
*   **Relative Divergence:** 6.7% (FSLR is currently positioned at the 6.7th percentile within its historical divergence range relative to VOO.)

**Analysis:** FSLR has significantly underperformed the S&P 500 over the analyzed period. The relative divergence suggests that FSLR's current underperformance is near the lower end of its historical range compared to the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha    | Beta   | Cap(B) |
|------------|---------|-------|----------|--------|--------|
| 2015-2017  | 37.0%   | 67.2% | 9.0%     | 0.0    | 7.2    |
| 2016-2018  | -32.0%  | 73.3% | -47.0%   | -0.0   | 4.5    |
| 2017-2019  | 34.0%   | 73.3% | 11.0%    | -0.3   | 6.0    |
| 2018-2020  | 11.0%   | 81.1% | -13.0%   | -0.3   | 10.6   |
| 2019-2021  | 55.0%   | 81.1% | 8.0%     | -0.9   | 9.3    |
| 2020-2022  | 130.0%  | 81.1% | 131.0%   | 0.2    | 16.1   |
| 2021-2023  | 33.0%   | 80.7% | 31.0%    | 1.4    | 18.5   |
| 2022-2024  | 22.0%   | 84.0% | 1.0%     | 1.2    | 18.9   |
| 2023-2025  | -67.0%  | 84.0% | -129.0%  | 3.1    | 23.5   |

**Analysis:**

*   **CAGR:** Shows variable performance over different periods, with a significant negative CAGR in the most recent period (2023-2025).
*   **MDD:** Consistently high Maximum Drawdown, indicating significant price volatility.
*   **Alpha:**  Fluctuates significantly, being strongly positive in some periods (2020-2022, 2021-2023) and deeply negative in the most recent (2023-2025), suggesting varying degrees of outperformance relative to its benchmark.
*   **Beta:** Increased beta in recent years indicates a more volatile stock.

### 2. Recent Price Action

*   **Current Price:** $219.02
*   **Previous Close:** $223.53
*   **Change:** -$2.02 (-0.90%)
*   **5-day Moving Average:** $219.40
*   **20-day Moving Average:** $209.36
*   **60-day Moving Average:** $192.46

**Analysis:** The stock is currently trading below its 5-day moving average but above its 20-day and 60-day moving averages, suggesting a potential short-term downtrend within a longer-term uptrend.  The recent price decrease, while not dramatic, warrants attention in conjunction with other indicators.

### 3. Technical Indicators & Outlook

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 69.56 (Approaching overbought territory)
*   **PPO:** 0.26 (Positive, indicating bullish momentum)
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Divergence Change:** 3.1 (+) (Short-term increase)
*   **Expected Return:** 11.9% (Long-term, relative to S&P 500)

**Analysis:**

*   The high MRI suggests a favorable environment for investment, although this should be considered alongside other risk factors.
*   The RSI nearing 70 indicates the stock may be approaching overbought conditions, potentially signaling a pullback.
*   The positive PPO supports the idea of continued bullish momentum, but the RSI suggests caution.
*   The Hybrid Signal leans bullish, recommending full investment.
*   The recent increase in relative divergence is a positive sign.
*   The 11.9% expected return (over 2+ years) suggests optimism in FSLR's long-term outperformance potential.
*   The price change of -2.02 indicates a slight downward fluctuation, and its potential impacts are already reflected in technical indicators such as RSI and moving averages.

### 4. Recent News & Significant Events

*   **Positive Headlines:** Several articles highlight FSLR exceeding market returns and the potential benefits of its CuRe program. Analyst opinions are also generally positive.
*   **Mixed Headlines:** Some articles advise caution regarding FSLR and point out that it has experienced a more significant dip than the broader market.

**Analysis:** The recent news presents a mixed picture. While some sources highlight FSLR's strengths and market outperformance, others express caution and note recent underperformance. The focus on the CuRe program suggests innovation and potential future growth.

### 4-2. Analyst Opinions

*   **Consensus:** Buy
*   **Mean Rating:** 1.59 (~Buy)
*   **Number of Opinions:** 30
*   **Target Price (avg/high/low):** $221.53 / $287.00 / $100.00

**Analysis:** The analyst consensus is strongly positive, with a "Buy" rating.  The average target price suggests a slight upside from the current price.  The wide range between the high and low target prices indicates differing opinions and potential volatility.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-07-31 | 3.19 | 1.10 B$  |
| 2025-04-29 | 1.96 | 0.84 B$  |
| 2024-10-29 | 2.92 | 0.89 B$  |
| 2024-07-30 | 3.26 | 1.01 B$  |
| 2025-07-31 | 3.26 | 1.01 B$  |

**Analysis:** The data shows fluctuating EPS and revenue figures, indicating variability in FSLR's recent financial performance. The absence of a clear upward trend requires further investigation into the factors influencing these fluctuations.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $1.10B     | 45.56%        |
| 2025-03-31   | $0.84B     | 40.78%        |
| 2024-12-31   | $1.51B     | 37.49%        |
| 2024-09-30   | $0.89B     | 50.17%        |
| 2024-06-30   | $1.01B     | 49.37%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-06-30   | $8.55B     | 4.00%     |
| 2025-03-31   | $8.19B     | 2.56%     |
| 2024-12-31   | $7.98B     | 4.93%     |
| 2024-09-30   | $7.59B     | 4.12%     |
| 2024-06-30   | $7.26B     | 4.82%     |

**Analysis:**

*   **Revenue & Profit Margin:** While revenue fluctuates, profit margins have generally remained strong, suggesting efficient cost management. The peak in revenue in Q4 2024 should be investigated for its drivers.
*   **Equity & ROE:** Equity has consistently grown, reflecting the company's increasing net worth. ROE (Return on Equity) shows variability, indicating fluctuations in profitability relative to shareholders' equity.

### 7. Overall Summary

FSLR presents a mixed picture.

*   **Positives:**
    *   Strong analyst consensus (Buy).
    *   Positive long-term expected return.
    *   High MRI indicating a favorable investment environment.
    *   Solid profit margins and growing equity.
    *   Innovation through the CuRe program.
*   **Negatives/Cautions:**
    *   Significant underperformance relative to the S&P 500 in the recent past.
    *   High Maximum Drawdown indicates volatility.
    *   RSI approaching overbought territory.
    *   Fluctuating revenue and EPS.
    *   Mixed recent news headlines.
    *   Increased Beta indicating a more volatile stock.

**Recommendation:**

Based on this analysis, FSLR appears to be a company with strong potential but also significant risk. The positive analyst consensus, long-term expected return, and favorable MRI suggest a potential buying opportunity. However, the underperformance relative to the S&P 500, high volatility, and mixed news headlines warrant caution.

**Before making any investment decisions, it is crucial to:**

*   Conduct further research into the drivers of FSLR's fluctuating revenue and EPS.
*   Assess your own risk tolerance and investment horizon.
*   Consider diversifying your portfolio to mitigate risk.
*   Closely monitor FSLR's performance and news updates.
